ABBOTINDIA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.2
| Stock Code | ABBOTINDIA | Market Cap | 55,853 Cr. | Current Price | 26,298 ₹ | High / Low | 37,000 ₹ |
| Stock P/E | 36.6 | Book Value | 1,888 ₹ | Dividend Yield | 1.81 % | ROCE | 46.2 % |
| ROE | 35.7 % | Face Value | 10.0 ₹ | DMA 50 | 27,243 ₹ | DMA 200 | 28,896 ₹ |
| Chg in FII Hold | 0.03 % | Chg in DII Hold | -0.11 % | PAT Qtr | 376 Cr. | PAT Prev Qtr | 415 Cr. |
| RSI | 42.2 | MACD | -126 | Volume | 9,155 | Avg Vol 1Wk | 8,033 |
| Low price | 26,000 ₹ | High price | 37,000 ₹ | PEG Ratio | 1.74 | Debt to equity | 0.05 |
| 52w Index | 2.71 % | Qtr Profit Var | 4.21 % | EPS | 717 ₹ | Industry PE | 27.6 |
📉 Chart & Trend: Current price (26,298 ₹) is below both 50 DMA (27,243 ₹) and 200 DMA (28,896 ₹), confirming short-term weakness and a bearish bias.
📊 RSI: At 42.2, RSI is neutral but leaning bearish, showing limited buying strength.
📉 MACD: Negative (-126), indicating bearish crossover and weak momentum.
📈 Bollinger Bands: Price is near the lower band, suggesting oversold conditions but no confirmed reversal yet.
📉 Volume: Current volume (9,155) is slightly above 1-week average (8,033), showing mild participation but not strong accumulation.
📍 Support Levels: 26,000 ₹ (near-term), 25,500 ₹ (major support), 24,000 ₹ (long-term support).
📍 Resistance Levels: 27,000 ₹ (near-term), 28,000 ₹ (major resistance), 29,000 ₹ (200 DMA resistance).
🔎 Momentum Signal: Weak short-term momentum with bearish bias.
📌 Trend Status: Consolidating with risk of reversal if support breaks.
Positive
- Strong ROCE (46.2%) and ROE (35.7%) indicate excellent efficiency.
- Low debt-to-equity ratio (0.05) ensures financial stability.
- Dividend yield of 1.81% provides income support.
- EPS of 717 ₹ reflects strong earnings power.
Limitation
- Stock trading below both 50 DMA and 200 DMA, confirming bearish trend.
- High P/E (36.6) compared to industry average (27.6), suggesting premium valuation.
- 52-week index performance only 2.71%, showing weak relative strength.
Company Negative News
- Quarterly profit declined from 415 Cr. to 376 Cr. (-4.21%).
- DII holding reduced (-0.11%), showing declining domestic institutional confidence.
Company Positive News
- FII holding increased (+0.03%), reflecting slight foreign investor support.
- Strong fundamentals with high efficiency ratios and consistent dividend payout.
Industry
- Industry P/E at 27.6 is lower than company’s P/E (36.6), highlighting premium pricing risk.
- Pharmaceutical sector remains stable with long-term demand visibility.
Conclusion
⚠️ ABBOTINDIA is consolidating with weak short-term signals (negative MACD, neutral RSI, below DMA). Entry is favorable near 26,000–26,300 ₹ with strict stop-loss at 25,500 ₹. Exit zones lie around 27,000–28,000 ₹, with breakout potential toward 29,000 ₹ if momentum strengthens. Fundamentals remain strong with high ROCE/ROE and dividend support, but short-term weakness and premium valuation raise caution. Traders should wait for confirmation signals; long-term investors may accumulate gradually on dips for sustained exposure to the pharma sector.